Relixir Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2011.
2011 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Relixir Pharmaceuticals Private Limited

Relixir Pharmaceuticals Private Limited, a active private limited company, was established on 14 February 2011 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2011PTC072584. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.50 Cr and a paid-up capital of ₹10.50 Cr.

It upholds a compliant status. Employing 60 professional, Its leadership includes Anil Kumar Devanapalli Ramaya (Director), Vinutha Mandula (Director). Past directors included Thirupathi Reddy Lakkireddy, Nischal Yachamaneni. It holds no open charges and ₹26.81 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at P.No. 24, 1-89/A/8/1/24, Trendz Jr, 4B, Gaffor Nagar, Madhapur, Hyderabad, Telangana, 500081.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2011PTC072584

  • Registration Number

    072584

  • Incorporation Date

    14 February 2011

  • Authorized Capital

    ₹10.50 Cr

  • Paid-Up Capital

    ₹10.50 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.50 Cr
  • Paid Up Capital ₹ 10.50 Cr
  • Company Age 15 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 26.81 Cr
  • Revenue Growth **** -43.65%
  • Profit Growth **** -57.40%
  • Ebitda **** -34.93%
  • Net Worth 8.24%
  • Total Assets **** 1.02%
Company report

Relixir Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Relixir Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Relixir Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Anil Kumar Devanapalli Ramaya Director 14 Feb 2011 Current
Vinutha Mandula Director 10 Oct 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 22 Dec 2016 Past
Pramod Abcsdd Director 22 Oct 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Relixir Pharmaceuticals.

Relixir Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 43.65% decrease. The company also saw a substantial fall in profitability, with a 57.4% decrease in profit. The company's net worth moved up by a moderate rise of 8.24%.

Relixir Pharmaceuticals revenue growth over time
Relixir Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -43.65%
*******
*******
*******
*******
Revenue from Operations
*******
 -43.70%
*******
*******
*******
*******
Total Assets
*******
 1.02%
*******
*******
*******
*******
Profit or Loss
*******
 -57.40%
*******
*******
*******
*******
Net Worth
*******
 8.24%
*******
*******
*******
*******
EBITDA
*******
 -34.93%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Relixir Pharmaceuticals?

In 2022, Relixir Pharmaceuticals had a promoter holding of 95.80% and a public holding of 4.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹268,100,000.00

Charges Breakdown by Lending Institutions
  • Others : 26.81 Cr
Latest Charge Details
Date Lender Amount Status
30 Apr 2022 Others ₹1.45 Cr Satisfied
23 Nov 2020 Others ₹7.00 M Satisfied
16 Aug 2017 Others ₹24.66 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Relixir Pharmaceuticals?

Relixir Pharmaceuticals has a workforce of 60 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Relixir Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relixir Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Relixir Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Relixir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Relixir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.

  • Charges

    A charge registered on 30 Apr 2022 via Charge ID 100581030 with Others was fully satisfied on 23 Mar 2023. was recorded as a recent event.

  • Charges

    A charge registered on 23 Nov 2020 via Charge ID 100394867 with Others was fully satisfied on 23 Mar 2023. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 16 Aug 2017 via Charge ID 100131752 with Others was fully satisfied on 23 Mar 2023. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 1.45 Cr with Charge ID 100581030 was registered on 30 Apr 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Relixir Pharmaceuticals Private Limited?

The CIN of Relixir Pharmaceuticals Private Limited is U24100TG2011PTC072584.

Where is Relixir Pharmaceuticals Private Limited headquartered?

Relixir Pharmaceuticals Private Limited is headquartered at P.No. 24, 1-89/A/8/1/24, Trendz Jr, 4B, Gaffor Nagar, Madhapur, Hyderabad, Telangana, 500081.

When was Relixir Pharmaceuticals Private Limited incorporated?

Relixir Pharmaceuticals Private Limited was incorporated on 14 February 2011.

Who are the current directors of Relixir Pharmaceuticals Private Limited?

The current directors of Relixir Pharmaceuticals Private Limited are

What is the primary industry of Relixir Pharmaceuticals Private Limited?

The primary industry of Relixir Pharmaceuticals Private Limited is Manufacturing.

Is Relixir Pharmaceuticals Private Limited a listed company?

Relixir Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Relixir Pharmaceuticals Private Limited?

The authorized capital of Relixir Pharmaceuticals Private Limited is ₹10.50 Cr, and the paid-up capital is ₹10.50 Cr.

What is the compliance status of Relixir Pharmaceuticals Private Limited?

The compliance status of Relixir Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available